Exclusion Criteria:~* Dementia or neurocognitive disorder (NCD) due to a condition other than AD, including,
but not limited to, frontotemporal dementia, Parkinson disease, dementia with Lewy bodies, Huntington disease,
or vascular dementia~* History or presence of clinically evident vascular disease potentially affecting the
brain that in the opinion of the investigator has the potential to affect cognitive function~* History or
presence of stroke within the past 2 years or documented history of transient ischemic attack within the last
12 months~* History or presence of systemic autoimmune disorders potentially causing progressive neurologic
disease with associated cognitive deficits~* History of schizophrenia, schizoaffective disorder, or bipolar
disorder~* Alcohol and/or substance use disorder (according to the DSM-5) within the past 2 years (nicotine use
is allowed)~* History or presence of atrial fibrillation~* Within the last 2 years, unstable or clinically
significant cardiovascular disease (e.g., myocardial infarction, angina pectoris, cardiac failure New York
Heart Association Class II or higher)~* Uncontrolled hypertension~* Chronic kidney disease~* Impaired hepatic
function~PET imaging substudy, in addition to above:~- Prior participation in other research study or clinical
care within the last year such that the total radiation exposure would exceed the local or national annual
limits~Part 2 Participants who have been discontinued from the study
